Trophogen Inc.

Calculating rank

USPTO Granted Patents = 8

% Expired Patents = 12.5

CIPO Patents = 2

EPO Patents = 4

Forward Citations = 7

Loading Chart...

2 inventors (with patents filed for the assignee):

Mariusz Szkudlinski (8 out of 8 patents)

Bruce D Weintraub (8 out of 14 patents)

Mariusz W Szkudlinski (4 patents)

8 patents: Sort by Forward Citations

1. 10766941 - Glycoprotein hormone long-acting superagonists (2020-09-08),

2. 10544200 - Glycoprotein hormone long-acting superagonists (2020-01-28),

3. 10457713 - Glycoprotein hormone long-acting superagonists (2019-10-29),

4. 9249205 - Glycoprotein hormone long-acting superagonists (2016-02-02),

5. 9187545 - Glycoprotein hormone long-acting superagonists (2015-11-17),

6. 9078860 - VEGF analogs (2015-07-14),

7. 8759285 - VEGF superagonists and methods of use (2014-06-24),

8. 8377879 - Follicle stimulating hormone superagonists (2013-02-19),

Company Overview

Trophogen Inc. is a biotechnology company focused on developing innovative therapies for cancer. With a team of experienced researchers and scientists, Trophogen is dedicated to advancing novel treatments that target specific pathways in cancer cells. The company's mission is to improve patient outcomes and quality of life through cutting-edge research and development.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

8 Patents

#82 in Rockville, MD

#505 in Maryland

#35,954 in US

Rockville, MD, United States of America

Trophogen Inc.

Forward Citations = 7

2 inventors:

Mariusz Szkudlinski (8 out of 8 patents)

Bruce D Weintraub (8 out of 14 patents)

Mariusz W Szkudlinski (4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Trophogen Inc.. Retrieved from https://idiyas.com/company/trophogen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]